Skip main navigation

Worldwide
worldwide_img

Home > Worldwide > Takeda Pharmaceuticals North America, Inc.

Skip side navigation

Main contents starts here

Takeda Pharmaceuticals North America, Inc.

Home page
Business Marketing
Key Products (pioglitazone hydrochloride)
(pioglitazone HCl and metformin HCl)
(pioglitazone HCl and glimepiride)
(lubiprostone)*
(ramelteon)
(lansoprazole)
(dexlansoprazole)
(febuxostat)
*Amitiza is a trademark of Sucampo Pharmaceuticals, Inc.
Address One Takeda Parkway, Deerfield, IL 60015, USA
Telephone +1-224-554-6500
Contact
Founded 1998
   

Takeda Pharmaceuticals North America, Inc. (TPNA) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
In the United States, TPNA currently markets oral diabetes, sleep, gastroenterology, cholesterol lowering treatments and chronic management of hyperuricemia in patients with gout, and through the Takeda Global Research & Development Center, Inc. the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions.


[*]The information presented at each company's website is governed by laws and regulations of that particular country, and therefore is intended for residents in that country only.

Photo

Takeda Pharmaceuticals North America, Inc.

Related Links

Page Top